SCHEMBL1633170

SCHEMBL1633170

CN1CCN(c2cccc(Nc3ncc4ccc(OC5CCNCC5)cc4n3)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 1/20 0.49
JAK2 O60674 3/20 0.48
JAK1 P23458 2/20 0.48
JAK3 P52333 2/20 0.48
WEE1 P30291 1/20 0.47
BRD4 O60885 7/20 0.46
MARK3 P27448 2/20 0.46
TYK2 P29597 1/20 0.45
TBK1 Q9UHD2 1/20 0.45
CCNA2 P20248 3/20 0.44
CDK2 P24941 3/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
CCNT1 O60563 2/20 0.44
CDK9 P50750 2/20 0.44
FLT3 P36888 2/20 0.44
MARK4 Q96L34 1/20 0.44
SYK P43405 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724942 0.93 MARK3 (0.49) JAK2JAK1JAK3BRD4MARK3
SCHEMBL1633265 0.90 SYK (0.54) JAK2JAK1JAK3TBK1CCNA2
SCHEMBL1634293 0.88 MAP4K1 (0.48) MAP4K1JAK2JAK1JAK3WEE1
SCHEMBL12724944 0.85 MARK3 (0.46) JAK2JAK1JAK3BRD4MARK3
SCHEMBL1634175 0.82 SYK (0.53) JAK2JAK1JAK3TYK2CCNA2
SCHEMBL1633219 0.81 SYK (0.49) JAK2JAK1JAK3TYK2FLT3
SCHEMBL12724910 0.81 SYK (0.49) JAK2JAK1JAK3TYK2FLT3
SCHEMBL1633769 0.81 HRH3 (0.43) MAP4K1JAK3BRD4CCNA2CDK2
SCHEMBL1633417 0.80 MAPK10 (0.57) JAK2TBK1CCNA2CDK2SYK
SCHEMBL1633454 0.79 SYK (0.46) JAK2JAK1JAK3TYK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed